Moderna and Merck announced the successful outcome of their Phase 3 combined treatment trials involving a new cancer vaccine and Keytruda.
3 reports, 3 independent
Updated Sun 00:00
No new developments lately
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Moderna and Merck announced the successful outcome of their Phase 3 combined treatment trials involving a new cancer vaccine and Keytruda.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.EC approved Keytruda/Padcev combo; Merck stock increased following positive Phase 3 results.1 source
Successful Phase 3 trial outcome announced for combined Moderna vaccine and Keytruda therapy.1 source